Related Experiment Video
Updated: Jun 20, 2026

13:28
Three-dimensional Confocal Analysis of Microglia/macrophage Markers of Polarization in Experimental Brain Injury
Published on: September 4, 2013
11.9K
KDM4A regulates microglial polarization after ischemic stroke by regulating SPINK5 signaling
Xiaoli Min1, Lei Xian1, Ting Liu2
1Department of Cerebrovascular Diseases, the Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China.
Acta Biochimica Et Biophysica Sinica
|September 26, 2025
Summary
Lysine-specific histone demethylase 4 (KDM4A) promotes brain injury after ischemic stroke by increasing pro-inflammatory microglial polarization. Inhibiting KDM4A reduces stroke severity and enhances recovery.
Area of Science:
- Neuroscience
- Molecular Biology
- Immunology
Background:
- Microglia/macrophage polarization is critical in ischemic stroke (IS) inflammation.
- Understanding the molecular regulation of this process is key to developing new therapies.
Purpose of the Study:
- To investigate the role of lysine-specific histone demethylase 4A (KDM4A) in regulating microglial polarization post-ischemic stroke.
- To elucidate the molecular mechanisms underlying KDM4A's function in ischemic stroke.
Main Methods:
- Established in vivo (MCAO) and in vitro (OGD) models of ischemic stroke.
- Utilized TTC staining, RT-qPCR, immunofluorescence, Western blot, ChIP assay, and TUNEL assay to assess infarct size, gene/protein expression, microglial polarization, and apoptosis.
Main Results:
- KDM4A was upregulated in ischemic stroke models.
- KDM4A downregulation improved neurological function, motor capacity, and reduced inflammation and pro-inflammatory microglial activation.
- KDM4A reduced H3K9me3 on the SPINK5 promoter, increasing SPINK5 expression, which in turn inhibited M2 microglial polarization and neuronal apoptosis.
Conclusions:
- KDM4A exacerbates ischemic stroke brain injury by promoting pro-inflammatory microglial polarization through the SPINK5 signaling pathway.
- Targeting KDM4A may represent a therapeutic strategy for mitigating ischemic stroke-induced brain damage.

